This opens up the possibility that the moderately elevated serum level of SAA in obesity could be an inert marker of insulin resistance instead of playing an active role in the development of type 2 diabetes and the obesity-related inflammation. This evidence concerns the gene SAA1 and obesity due to melanocortin 4 receptor deficiency.